This study focuses on patients who are receiving care for non-metastatic pancreatic cancer at Cedars-Sinai. The purpose of the study is to evaluate the role of a method of magnetic resonance imaging (MRI) analysis for individuals with pancreatic ductal adenocarcinoma (PDAC). Researchers aim to determine whether their newly developed, six-dimensional magnetic resonance imaging (6D-MRI) is effective in predicting outcomes to therapy in PDAC patients. 6D-MRI is a type of image analysis that can visualize high-resolution images of the pancreas and pancreatic tumors taken during MRI scans. These non-standard imaging techniques are for research purposes only. Participants will be asked to undergo 3 separate 6D-MRI procedures during the course of their cancer treatment. 6D-MRI provides a more complex analysis of images generated during the MRI than images from a standard MRI; there are no procedural differences between 6D-MRI and standard MRI. Participants should not expect to benefit from taking part in this study. Researchers hope to learn whether specific findings in the 6D-MRI can help select the best therapy for other patients in the future with the result of improving outcome.